The New York Times (NY) – Much-Debated Treatment for Heart Disease Shows Slight Benefit in Clinical Trial– By Andrew Pollock – (Sunday, November 4, 2012)


To the surprise of many cardiologists, a controversial alternative therapy proved beneficial to people with heart disease, reducing the rate of death and cardiovascular problems in a clinical trial, researchers said on Sunday.


The benefit of the treatment, known as chelation therapy, barely reached statistical significance, and there were questions about the reliability of the study. Even the investigators in the trial said the results were insufficient by themselves to justify recommending use of the treatment.